Sweef Capital invests in USM Healthcare

USM was founded in 2012 by Vo Xuan Boi Lam, a prominent figure in medical device manufacturing in Vietnam. Lam identified a strong need for domestic capabilities that would help Vietnam reduce its dependence on imported high-tech cardiovascular devices.

USM currently produces coronary stent systems, PTCA balloon catheters, and intravenous catheters used in interventional cardiology. Its product range also encompasses cardiovascular accessories, medical consumables, traumatology, and orthopaedic products.

Much like the groundbreaking strides with cardiovascular products, Lam sees vast potential in establishing domestic production capabilities for orthopaedic products. This expansion direction underscores her commitment to bolstering self-sufficiency and innovation in Vietnam’s healthcare industry.

This strategic move diversifies the company's portfolio and places it at the forefront of addressing the growing demand for orthopaedic solutions in Vietnam and beyond. USM has also successfully ventured into export markets, marking another milestone in its growth story.

USM’s broad portfolio aligns perfectly with SWEEF’s overarching mission to support and promote innovative enterprises led by women. This collaboration strengthens the company’s position and highlights the potential for making a transformative impact through gender equality and diversity.

Lam said, "We warmly welcome SWEEF’s investment, recognising it as more than a financial partnership. It is a strategic alliance, fortified by our common commitment to drive transformative change. Together, we are dedicated to ensuring that affordable medical devices and orthopaedic products are accessible to those in need."

“Beneath the surface of this shared commitment lies a deeper purpose – the promotion of women’s economic empowerment. This goal is pursued through the creation of employment opportunities and the implementation of supportive workplace policies that contribute to a more innovative and resilient Vietnamese health sector,” she added.

Jennifer Buckley, managing director of Sweef Capital said, "SWEEF’s investment in USM is a pivotal step advancing the cause of accessible and affordable healthcare in Vietnam. It’s a commitment to improving health outcomes and reducing mortality rates, particularly those attributed to cardiovascular disease."

"At the heart of this transformative journey is a remarkable woman entrepreneur. Lam recognised the urgent need for domestic manufacturing capabilities to ensure that essential devices and orthopaedic products are readily accessible to the Vietnamese population. She’s a role model in how she focuses on addressing unmet community needs in a sector where women aren’t commonly found in leadership positions," Buckley continued.

SWEEF’s first investment was in the Vietnamese edtech company, TEKY, in May.

GE HealthCare's 30-year journey to transform Vietnam's healthcare sector During its 30 years of operation in Vietnam, GE HealthCare has played an active role in closing the care gaps, thereby contributing to the sector's sustainable future.

Medtronic at forefront of transforming Vietnam’s healthcare Vietnam’s healthcare industry has undergone drastic changes in recent years. More innovations in medical technology, pharmaceuticals, and treatment approaches have been developed to transform patient care and outcomes.

Thomson Medical Group eyes robust growth in Vietnam through strategic M&A initiatives Speaking at the 15th Vietnam M&A Forum 2023 themed Thriving Together that was organised by VIR on November 28, Dr. Melvin Heng, executive director and group CEO of Thomson Medical Group, emphasised the pivotal role of mergers and acquisitions (M&A) in this expansion.